Related Experiment Video

Updated: Apr 30, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.1K

MicroRNA-223 functions as an oncogene in human colorectal cancer cells

Jufeng Zhang1, Xia Luo2, Huiming Li3

  • 1School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China.

Oncology Reports
|May 14, 2014
PubMed

Insights

Aberrant microRNA-223 (miR-223) expression correlates with colorectal cancer (CRC) progression. Silencing miR-223 inhibits CRC cell proliferation, migration, and invasion, identifying it as a potential diagnostic and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Aberrant microRNA (miRNA) expression is common in colorectal cancer (CRC), but their specific roles in disease progression are not fully understood.
  • MicroRNAs are small non-coding RNA molecules that play crucial roles in regulating gene expression and are implicated in various cancers.

Purpose of the Study:

  • To identify and characterize specific miRNAs associated with colorectal cancer progression.
  • To investigate the functional role of microRNA-223 (miR-223) in colorectal cancer cell behavior.

Main Methods:

  • miRNA microarray analysis of colorectal tumor tissues to screen for deregulated miRNAs.
  • Quantitative real-time PCR validation in a large cohort of CRC samples (n=90).
  • Functional assays including cell proliferation (WST-1, colony formation), migration (wound healing), and invasion (Transwell) after miR-223 inhibition.

Main Results:

  • Twenty-two miRNAs showed significant differential expression in CRC tissues compared to adjacent non-tumor tissues.
  • MicroRNA-223 (miR-223) was identified as a notably upregulated miRNA in CRC.
  • Higher miR-223 levels correlated with advanced clinical stages in CRC patients.
  • Inhibition of miR-223 significantly reduced colorectal cancer cell proliferation, migration, and invasion.

Conclusions:

  • MicroRNA-223 functions as an oncomiR in colorectal cancer.
  • miR-223 represents a potential diagnostic biomarker and therapeutic target for colorectal cancer treatment.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K